Endo Tool Therapeutics closes $5.7M funding round — 4 insights

Endo Tool Therapeutics raised $5.7 million (€5 million) in a series C financing round, which the company will use to support future studies and device development, Mass Device reports.

What you should know:

1. Epimède led the round, joined by several current investors.

2. Epimède Co-founder Philippe Degeer will join the company's board of directors.

3. Endo Tool will also use the funds to support the continued development of its Endomina, endoscopy platform.

4. Endo Tool CEO Alexandre Chau said in a statement, "With technical and regulatory challenges behind us, these funds will allow Endo Tools Therapeutics to achieve further proof of efficacy of treatments performed with our devices, as well as wider adoption."

More articles on supply chain:
Georgia widens scope of CON bill — 5 insights
Gastro Health acquiring Gastroenterology Specialists, continuing Florida expansion efforts — 4 insights
New Jersey appellate court rules on PIP procedures

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months